Are you ready to lead the next wave of transformation in life sciences? Across Navitas’ industry-leading networks, pvnet^®, pvconnect^®, labelnet^™, and more, over 100+ member companies are rewriting the playbook for 2026. Here’s what’s setting the pace for the industry’s boldest innovators:

1. Technology & Automation: From Hype to High-Impact

Forget pilots and prototypes—2026 is about scaling real value. The consensus? Technology isn’t the differentiator anymore; delivering measurable impact is.

• AI in Safety Operations: pvnet^® members are moving beyond ‘is AI good?’ to ‘how do we maximize its value?’
• Automation at Scale: pvconnect^® is all about building frameworks that work—integrated, interoperable, and future-proof.
• Labeling Intelligence: labelnet^™ is harnessing AI to make digital labeling smarter, faster, and more strategic.

Bottom line: The era of endless experimentation is over. It’s time for scalable, value-driven digital transformation.

2. Digital & AI: Redefining Excellence

Digital transformation is no longer a buzzword—it’s the new baseline.

• AI Across the Lifecycle: From R&D to regulatory, AI is reshaping every function.
• Data-Driven Decisions: Members are laser-focused on embedding AI without adding compliance risk.
• AI-First Workflows: The winners will be those who build AI-native operating models—not those who retrofit old systems.

Key question: How will you redesign your workflows to thrive in an AI-powered world?

3. Regulatory Expectations: The Bar Keeps Rising

With sweeping EU pharma legislation and global regulatory shifts, the pressure is on.

• Continuous Change: Regulatory transformation is now a marathon, not a sprint.
• Proactive Planning: Future-ready strategies demand digital readiness and cross-functional alignment.
• Vendor Oversight & Sourcing: Members are rethinking partnerships and compliance for a new era.

Takeaway: Regulatory excellence is about staying ahead—anticipate, adapt, and align.

4. Talent, Mindset & Sourcing: Building Tomorrow’s Workforce

People are the real engine of transformation.

• Upskilling for the Future: Hybrid roles blending tech, regulatory, and digital skills are in high demand.
• Career Path Clarity: Labeling and PV professionals are seeking new growth opportunities.
• Capability Building: The new competitive edge is a workforce that’s AI-ready and digitally fluent.

Mantra: Capability-building isn’t optional—it’s your ticket to leadership.

Navitas Networks: Your Launchpad for Strategic Transformation

What sets Navitas apart? It’s not just about sharing knowledge—it’s about turning insights into action.

• Benchmarking: See where you stand and where you can leap ahead.
• Collective Intelligence: Leverage the power of 112 companies to accelerate your journey.
• Actionable Insights: Move from discussion to decisive transformation.

2026 Preview: Get ready for expanded agendas—AI roadmaps, digital labeling strategies, sourcing innovation, and more.

Why Join? The Power of Peer Networks

• Clarity: Spot trends and risks before they hit.
• Confidence: Validate your strategies with real-world evidence.
• Capability: Access best practices and tools that drive operational maturity.

Peer networks turn isolated questions into industry-aligned solutions—fast.

Ready to Lead with Insight? Join Today!

Networks Memberships are now OPEN! Secure your place and set your team up for success in 2026. Connect with the industry’s most influential network for safety and regulatory professionals.

1. “What are the Navitas industry networks?”
Navitas Life Sciences’ industry networks are globally recognized peer-to-peer platforms that bring together leaders from over 112 pharmaceutical and biotech organizations. Established in 2001, they offer a confidential environment where safety, regulatory and labeling professionals openly exchange challenges, benchmark practices and shape the future of life sciences operations. These networks are strategic communities that drive alignment, innovation and collective problem-solving across the industry.

2. “What topics are discussed in life sciences peer networks?”
Across Navitas' networks, discussions consistently focus on the areas that matter most to today’s life sciences leaders, including:

• AI and automation adoption across PV, regulatory, and labeling workflows
• EU pharma legislative changes and global regulatory expectations
• Sourcing and operating model evolution
• Digital labeling transformation and structured content
• Signal detection innovations and data analytics
• Talent strategy, workforce upskilling and capability building

These conversations reveal both shared challenges and emerging best practices, helping companies stay ahead of industry shifts.

3. What is the significance of benchmark insights from pharma safety and regulatory networks.
Navitas’ benchmark insights enable members to understand where they stand relative to peers across multiple dimensions:

• Automation maturity in safety case processing and regulatory submissions
• Adoption of AI-driven signal management and labeling intelligence
• Compliance readiness for upcoming global regulatory changes
• Operational efficiency across PV, labeling, and regulatory teams
• Sourcing models and partner oversight strategies
• Technology adoption trends, including cloud-native safety and RIM platforms

These insights allow companies to make evidence-based decisions and build stronger business cases for transformation.

4. How do industry networks help pharma companies transform operations?
Navitas’ networks serve as a strategic catalyst for transformation by enabling companies to:

• Validate ideas and investment decisions before scaling
• Learn from real-world implementations
• Align safety, regulatory, and labeling priorities with evolving global expectations
• Leverage collective intelligence to shape automation and AI roadmaps
• Benchmark maturity and define future-state operating models
• Build organization-wide alignment through shared insights

By turning discussion into actionable transformation, the networks help companies adapt faster and more confidently.

5. What is the value of peer networks in pharmacovigilance and regulatory affairs?
For PV and Regulatory teams, peer networks provide three major sources of value:

1. Clarity: Members gain early visibility into regulatory trends, technology shifts and industry risks.
2. Confidence: Peer validation strengthens business cases for automation, sourcing changes or strategic redesign.
3. Capability: Members gain access to best practices, tools and benchmark data that elevate operational maturity.

Navitas’ networks help teams move from reactive problem-solving to proactive, intelligence-led operations.

6. How peer networks influence pharma innovation and compliance.
Navitas’ networks enable companies to benchmark in real time, pressure-test transformation ideas, validate technology investment decisions and share opposing viewpoints on sourcing, AI, automation and regulatory interpretations.

They act as industry accelerators, helping members:

• Identify emerging risks early
• Calibrate responses to regulatory change
• Adopt innovations faster and more confidently
• Build consensus on future operating models
• Strengthen internal business cases using industry evidence

In essence, peer networks turn isolated questions into industry-aligned solutions, increasing both innovation speed and compliance

Learn more about our services and solution by reaching out to us at This email address is being protected from spambots. You need JavaScript enabled to view it..